CME GroupCME -4.41%81 Days Payable is 30.12 as of Mar. 2026, which is 10% below its 10-year median of 33.33. GuruFocus rates CME with a GF Score™ of 81/100 and a GF Value™ of $270.93 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 539 Capital Markets companies, CME Group ranks worse than 65.12% on this metric.
CME Group's average Accounts Payable for the
three
months ended in Mar. 2026 was $74 Mil. CME Group's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $223 Mil.
Hence, CME Group's Days Payable for the
three
months ended in Mar. 2026 was 30.12.
The historical rank and industry rank for CME Group's Days Payable or its related term are showing as below:
CME'
s Days Payable Range Over the Past 10 Years
Min: 18.44 Med: 33.33 Max: 46.69
Current: 32.78
During the past 13 years, CME Group's highest Days Payable was 46.69. The lowest was 18.44. And the median was 33.33.
CME's Days Payable is ranked worse than 65.12% of 539
companies
in the Capital Markets industry
Industry Median: 91.02
vs CME: 32.78
CME Group's Days Payable
declined
from Mar. 2025 (39.75) to Mar. 2026 (30.12).
It may suggest that CME Groupaccelerated paying its suppliers.
CME Group Days Payable Related Terms
CME Group Days Payable Historical Data
* Premium members only.
The historical data trend for CME Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Financial Data & Stock Exchanges subindustry, CME Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Days Payable vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Days Payable distribution charts can be found below:
* The bar in red indicates where CME Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CME Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group (CME) has a Days Payable of 30.12 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CME Group and its competitors. This is 10% below median its historical median of 33.33. Over the past decade, CME Group's Days Payable has ranged from 18.44 to 46.69. According to the industry distribution chart, CME Group ranks #351 out of 539 companies in the Capital Markets industry, placing it in the top 65.1%.
Is CME Group's Days Payable too high?
CME Group's current Days Payable of 30.12 is 10% below median its 10-year median of 33.33. Over the past 10 years, this metric has ranged from a low of 18.44 to a high of 46.69. The Capital Markets industry median Days Payable is 91.02. CME Group's value of 30.12 is 66.9% below this industry median. Based on the distribution chart, CME Group ranks #351 out of 539 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Days Payable compare to ICE and MCO?
According to the Capital Markets industry distribution chart, CME Group ranks #351 out of 539 companies for Days Payable. This places CME Group in the lower half of its industry. The industry median Days Payable is 91.02. CME Group's value of 30.12 is 66.9% below this benchmark. Historically, CME Group's own Days Payable has ranged from 18.44 to 46.69 over the past decade. While the company's 10-year median is 33.33 vs. the industry median of 91.02, CME Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Capital Markets company?
The median Days Payable among Capital Markets companies is 91.02, based on 539 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Days Payable of 30.12 is 66.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Days Payable is 91.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Days Payable is 30.12, which is 10% below median its own 10-year median of 33.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.93, compared to a current price of $231.68 — trading 14.5% below its estimated fair value. The current Days Payable is 30.12, which is 10% below median its 10-year median of 33.33 and 66.9% below the Capital Markets industry median of 91.02. CME Group's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CME Group (CME), the current Days Payable is 30.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $231.68 is trading 14.5% below its estimated GF Value™ of $270.93.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
Days Payable: 30.12 (10% below median its 10-year median of 33.33)
GF Value™: $270.93 vs. price of $231.68 (14.5% below fair value)
Industry Position: 66.9% below the Capital Markets median (#351 of 539)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
81GF Score
Get the complete analysis for CME
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
